//FDA emergency authorization of blood plasma for Covid-19 on hold, according to the New York Times

FDA emergency authorization of blood plasma for Covid-19 on hold, according to the New York Times

A US Food and Drug Administration emergency use authorization for blood plasma to treat Covid-19 is on hold, but could still be issued in the near future, Dr. H. Clifford Lane, deputy director at the National Institute of Allergy and Infectious Diseases, told The New York Times.